Notice2025-01152
Agency Information Collection Activities; Proposed Collection; Improving the Quality and Representativeness of the Treatment Center Program Data-Data Modifications to the Current Survey Instrument Format to Minimize Misclassification; Withdrawal of Notice
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 17, 2025
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA) is announcing the withdrawal of a notice that was published in the Federal Register of October 18, 2023.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 11 (Friday, January 17, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 11 (Friday, January 17, 2025)]
[Notices]
[Page 5900]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-01152]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2023-N-3595]
Agency Information Collection Activities; Proposed Collection;
Improving the Quality and Representativeness of the Treatment Center
Program Data--Data Modifications to the Current Survey Instrument
Format to Minimize Misclassification; Withdrawal of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; withdrawal.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
withdrawal of a notice that was published in the Federal Register of
October 18, 2023.
DATES: The notice is withdrawn on January 17, 2025.
FOR FURTHER INFORMATION CONTACT: Darren Eicken, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave. Bldg. 51, Rm. 6206, Silver Spring, MD 20993-0002, 240-
402-0978.
SUPPLEMENTARY INFORMATION: In a notice published in the Federal
Register of October 18, 2023 (88 FR 71875), ``Agency Information
Collection Activities; Proposed Collection; Comment Request: Improving
the Quality and Representativeness of the Treatment Center Program
Data--Data Modifications to the Current Survey Instrument Format to
Minimize Misclassification.'' FDA requested comment on the information
collection associated with the proposed study entitled ``Improving the
Quality and Representativeness of the Treatment Center Program Data--
Data Modifications to the Current Survey Instrument Format to Minimize
Misclassification.''
Under the Paperwork Reduction Act of 1995, Federal Agencies are
required to publish notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
of an existing collection of information, and to allow 60 days for
public comment in response to the notice.
In the October 18, 2023, Federal Register notice, FDA proposed a
new collection of information. However, FDA no longer intends to
proceed with the proposed study due to circumstances and timing
surrounding the execution of the study. Therefore, we are withdrawing
the October 18, 2023 notice.
Dated: January 13, 2025.
P. Ritu Nalubola,
Associate Commissioner for Policy.
[FR Doc. 2025-01152 Filed 1-16-25; 8:45 am]
BILLING CODE 4164-01-P
</pre></body>
</html>Indexed from Federal Register on January 17, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.